Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 5Ovarian Neoplasms 3Small Cell Lung Carcinoma 2Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Fallopian Tube Neoplasms 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Rectal Diseases 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Neoplasms 1Digestive System Diseases 1Colorectal Neoplasms 1Colonic Diseases 1Carcinoma, Hepatocellular 1

Interventions

Etoposide 22Carboplatin 22Filgrastim 17Ifosfamide 15Cisplatin 14Peripheral Blood Stem Cell Transplantation 12Paclitaxel 12Cyclophosphamide 9Bleomycin 9Thiotepa 5Radiotherapy 5Therapeutics 4Temozolomide 4Psychiatric Rehabilitation 4Oxaliplatin 4Melphalan 4Granulocyte Colony-Stimulating Factor 4Gemcitabine 4sargramostim 3pegfilgrastim 3etoposide phosphate 3Methylprednisolone 3Dexamethasone 3Busulfan 3liposomal amphotericin B 2ixabepilone 2aldesleukin 2aflibercept 2Trastuzumab 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Testicular Neoplasms × guadecitabine × Clear all
NCT02429466 2020-09-23

Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors

Indiana University

Phase 1 Completed
14 enrolled
Genitourinary

Testicular Germ Cell Tumor, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡